Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
Antiprotozoal drugs
Other agents against amoebiasis and other protozoal diseases

XM0M05 category

Neosilversalvarsan

Also indexed as

Neosilversalvarsan

Nearby in Other agents against amoebiasis and other protozoal diseases

XM3E78Akritoin
XM8LB8Anti-infective arsenical
XM44A9Anti-infective heavy metals
XM8CX5Antimony anti-infectives
XM69W3Antimony potassium tartrate (sodium)
XM2AH2Antimony tartrated
XM1Z32Antiparasitic drug specified
XM0L93Arsphenamine (silver)

PreviousXM08P3 — Neoarsphenamine NextXM39N3 — Nifuratel

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
XM0QJ8Neuroprotective agents, not elsewhere classified
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
14 more
Systemic antibiotics and antibacterials
Antimycobacterials
Antifungal agents
Antiviral drugs
Antivenin, antivenom (sera), Immunoglobulin
Vaccines
Other specified systemic anti-infectives and antiparasitics
Antiprotozoal drugs
Anthelminthics
XM05U5Teclozan
XM6XS3Trichomonacides
XM5R30Tryparsamide
XM7BM9Nitroimidazole derivatives
XM4RW6Dichloroacetamide derivatives
XM4787Arsenic compounds
XM64G7Antimony compounds
Other agents against amoebiasis and other protozoal diseases
XM9JL2Eflornithine
21 more
XM6UT2Hexetidine
XM74Y8Iodobismitol
XM80M5Iodoquinol
XM7T64Lead anti-infectives
XM0FS9Mapharsen
XM0RW4Mercury, mercurial, mercuric, mercurous anti-infective systemic
XM08P3Neoarsphenamine
XM0M05Neosilversalvarsan
XM39N3Nifuratel
XM70Q8Oxolinic acid
XM10R8Potassium antimony tartrate
XM8WV6Quiniobine
XM8U22Quinoline (derivatives)
XM3VB9Salvarsan 606 (neosilver) (silver)
XM6260Silver salvarsan
35 more

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact